Dysregulated monocyte-derived macrophage response to Group B Streptococcus in newborns

Abstract

IntroductionStreptococcus agalactiae (Group B Streptococcus, GBS) is a leading pathogen of neonatal sepsis. The host-pathogen interactions underlying the progression to life-threatening infection in newborns are incompletely understood. Macrophages are first line in host defenses against GBS, contributing to the initiation, amplification, and termination of immune responses. The goal of this study was to compare the response of newborn and adult monocyte-derived macrophages (MDMs) to GBS.MethodsMonocytes from umbilical cord blood of healthy term newborns and from peripheral blood of healthy adult subjects were cultured with M-CSF to induce MDMs. M-CSF-MDMs, GM-CSF- and IFNγ-activated MDMs were exposed to GBS COH1, a reference strain for neonatal sepsis. ResultsGBS induced a greater release of IL-1β, IL-6, IL-10, IL-12p70 and IL-23 in newborn compared to adult MDMs, while IL-18, IL-21, IL-22, TNF, RANTES/CCL5, MCP-1/CCL2 and IL-8/CXCL8 were released at similar levels. MDM responses to GBS were strongly influenced by conditions of activation and were distinct from those to synthetic bacterial lipopeptides and lipopolysaccharides. Under similar conditions of opsonization, newborn MDMs phagocytosed and killed GBS as efficiently as adult MDMs. DiscussionAltogether, the production of excessive levels of Th1- (IL-12p70), Th17-related (IL-1β, IL-6, IL-23) and anti-inflammatory (IL-10) cytokines is consistent with a dysregulated response to GBS in newborns. The high responsiveness of newborn MDMs may play a role in the progression of GBS infection in newborns, possibly contributing to the development of life-threatening organ dysfunction.

Single-cell transcriptomics and Mendelian randomization reveal LUCAT1’s role in right-sided colorectal cancer risk

“…High variability genes in monocyte_C02 cells, including CXCL8, TNFAIP6, CXCL3, and SPP1, indicate a potential role in tumor promotion. Studies suggest CXCL8 can accelerate tumor cell proliferation, epithelial–mesenchymal transition (EMT), angiogenesis, and impede anti-tumor immunity ( Ravi et al, 2023 ). CXCL3, a bioactive protein of low molecular weight, primarily recruits and activates various cells expressing the CXC chemokine receptor (CXCR)12, which is involved in cell migration, invasion, and angiogenesis and plays a crucial role in the development of cardiovascular and pulmonary diseases ( Chang et al, 2023 ; Ji et al, 2023 ).…”